Tramadol drug market to reach $6.76 billion by 2030 at 7.4% CAGR, driven by rising prevalence of orthopedic disorders and increasing healthcare expenditure.
Read More
Temperature-stable messenger ribonucleic acid vial market to reach $3.77 billion by 2030 at 13.3% CAGR, driven by increasing participation in global vaccination programs.
Read More
Toxoplasmosis treatment drugs market to reach $4.66 billion by 2030 at 6.1% CAGR, driven by rising prevalence of toxoplasmosis infections.
Read More
Tcr therapy market to reach $1.15 billion by 2030 at 34.8% CAGR, driven by increasing incidence of cancer requiring advanced immunotherapies.
Read More
Toxicology drug screening market to reach $33.48 billion by 2030 at 9.2% CAGR, driven by rising prevalence of drug abuse worldwide.
Read More
Tazarotene market to reach $6.44 billion by 2030 at 7.1% CAGR, driven by increasing occurrence of skin diseases such as acne and psoriasis.
Read More
Topical wound agents market to reach $2.75 billion by 2030 at 7.5% CAGR, driven by rise in road accidents leading to traumatic injuries.
Read More
Targeted alpha-therapy market to reach $2.25 billion by 2030 at 17.0% CAGR, driven by growing focus on precision medicine in oncology care.
Read More
Topical drugs cdmo market to reach $121.22 billion by 2030 at 14.3% CAGR, driven by increasing prevalence of skin diseases requiring topical therapies.
Read More
Tardive dyskinesia treatment market to reach $3.9 billion by 2030 at 8.3% CAGR, driven by increasing prevalence of psychiatric disorders worldwide.
Read More